Recent Quotes (30 days)

You have no recent quotes
chg | %

Market summary

3:36PM EST

World markets

Shanghai 3,127.44 +18.85 (0.61%)
Nikkei 225 17,635.14 +13.74 (0.08%)
Hang Seng Index 23,408.57 +291.94 (1.26%)
TSEC 9,095.00 +95.48 (1.06%)
FTSE 100 6,576.74 +31.47 (0.48%)
EURO STOXX 50 3,154.91 +13.63 (0.43%)
CAC 40 4,254.43 +12.78 (0.30%)
S&P TSX 14,442.80 -25.46 (-0.18%)
S&P/ASX 200 5,442.00 +103.40 (1.94%)
BSE Sensex 27,701.79 +329.95 (1.21%)
TA25 1,481.14 -6.39 (-0.43%)
SMI 9,033.45 +57.21 (0.64%)
ATX 2,153.60
IBOVESPA 50,120.86 +469.88 (0.95%)
SET 1,536.83 +22.48 (1.48%)
BIST100 85,143.76 +1,570.21 (1.88%)
IBEX 10,371.00 +7.40 (0.07%)
WIG 51,487.54 +190.42 (0.37%)
TASI 8,546.87
MERVAL 7,460.11 +134.82 (1.84%)

Currencies

EUR/USD 1.2218 -0.0006 (-0.05%)
USD/JPY 119.9875 +0.4600 (0.38%)
GBP/USD 1.5575 -0.0053 (-0.34%)
USD/CAD 1.1643 +0.0032 (0.28%)
USD/HKD 7.7552 +0.0010 (0.01%)
USD/CNY 6.2230 +0.0006 (0.01%)
AUD/USD 0.8131 -0.0017 (-0.21%)

Bonds

3 Month 0.02% -0.01 (-33.33%)
6 Month 0.10% -0.01 (-9.09%)
2 Year 0.65% 0.00 (0.00%)
5 Year 1.66% +0.01 (0.61%)
10 Year 2.17% -0.01 (-0.46%)
30 Year 2.75% -0.03 (-1.08%)
Express Scripts drops Gilead hep C drugs for cheaper AbbVie rival
(Reuters) - The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's treatments after trying for nearly a year ...
AbbVie lowers price of hepatitis C drug to win deal with Express Scripts  
Express Scripts turns to new AbbVie drug in huge hepatitis C deal  
Market Chart
17,951.18 +146.38 (0.82%)
2,078.09 +7.44 (0.36%)
4,780.17 +14.79 (0.31%)

Top stories

China is stepping up its role as the lender of last resort to some of the world's most financially strapped countries. Chinese officials signaled Saturday that they are willing to expand a $24 billion currency swap program to help Russia weather the worst ...
Sales of previously owned U.S. homes slumped in November from a one-year high, underscoring the uneven nature of the current recovery in residential real estate that's been one of its defining characteristics.
NEW YORK (Reuters) - U.S. stocks rose on Monday, putting major indexes on track for a fourth straight daily gain, with gains in large-cap tech shares giving an outsized boost to the Dow.
The French industrial giant Alstom has agreed to plead guilty and pay a $772 million penalty to the United States in a bribery investigation by the Justice Department.
Benjamin Lawsky in November. The office of New York's top financial regulator announced a settlement with Ocwen on Monday. Bloomberg News.

Trends

Popular searches on GoogleChange Mkt Cap
OCN Ocwen Financial Corp -27.58% 2.51B
GILD Gilead Sciences, Inc. -13.85% 159.28B
CZR Caesars Entertainment Corp 11.82% 1.80B
GIL Gildan Activewear Inc (USA) 0.87% 7.01B
ACHN Achillion Pharmaceuticals, Inc. 8.82% 1.39B
ABBV AbbVie Inc -0.84% 108.04B
GI Gem International Resources Inc -45.10% 391,759.00
ACH Aluminum Corp. of China Limited (ADR) 0.78% 10.75B
TASR TASER International, Inc. 7.63% 1.26B
ABB ABB Ltd (ADR) 0.05% 49.45B

Sector summary

Sector Change % down / up
Energy -0.79%
Basic Materials -1.11%
Industrials +0.76%
Cyclical Cons. Goods ... +0.69%
Non-Cyclical Cons. Goods... +0.77%
Financials +0.34%
Healthcare -0.82%
Technology +1.06%
Telecommunications Servi... +0.97%
Utilities +0.39%